Bayer acquires Perfuse Therapeutics

Bayer agreed to acquire Perfuse Therapeutics. Reported deal value: Undisclosed. Status: Announced. Sector: ophthalmology. Target headquarters context: South San Francisco, California, United States.

This page summarizes publicly available information about the transaction as of 2026-05-11. Figures and status may change as filings and press coverage update.

Calendar Business Associations dba Financial Going Green International News Labs Private Equity Research + Stats Retailers Suppliers The Independent Eye VM Reports VM Summit Eyecare Coronavirus BRIEFING A Greater Vision Eye Health Health Watch Low Vision Managed Care Ophthalmology Optical on Main Street Opticianry Optometry Practice Management Telehealth Technology CLICK Contact Lenses Déjà View Digital + Social Media Exams/Dispensing Eye² Instruments LaunchPad Lens Processing Practice Software Spectacle Lenses Systems/Equipment Tools + Supplies VTO Systems Web Tech VM AIL Technology Archiv...